By Sarina Isaacs
Shares of Inotiv lost ground after the company priced a public offering of 6 million shares.
The stock was recently down 14.8% to $4.73 in premarket trading. As of Tuesday's close, it had gained about 60% over the past year.
The pharmaceutical company on Wednesday said it is offering 6 million common shares priced at $4.25 apiece, for a total of $25.5 million. Inotiv has also granted the underwriter a 30-day option to buy up to another 900,000 shares
The West Lafayette, Ind., company said net proceeds will go toward working capital, capital expenditures and other general corporate purposes.
The offering is expected to close Dec. 19.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
December 18, 2024 09:24 ET (14:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。